Background
PDA was founded in 1946 as the Parenteral Drug Association by a small group of pharmaceutical manufacturers who recognized the need for an organization to disseminate technical information within the industry. Today, coordinated through its headquarters and manufacturing training facility in Bethesda, Maryland, and Europe office in Berlin, Germany, PDA volunteers worldwide carry out its mission of promoting the exchange of rapidly evolving information on the latest technology and regulations concerning high-quality pharmaceutical production.
PDA is the recognized authoritative voice and leading technical organization in the field of parenteral science and technology. Through the development of Technical Reports and other documents and responses to regulatory initiatives, PDA and its members influence the future course of pharmaceutical products technology.
With more than 10,500 individual members worldwide, PDA draws its strength from the technical expertise of its membership. Conferences, meetings, and courses bring together pharmaceutical manufacturers, suppliers, users, academics, and regulatory officials to discuss and boost issues of mutual interest. These exchanges of technical knowledge, expertise, and best practices assist the advancement of pharmaceutical science and technology in the interest of public health.
The PDA Israel Chapter
The PDA Israel Chapter was founded in 1997 and is made up of the Executive committee, including the president, president-elect, treasurer and liaison with international PDA, and the Steering committee.
The Chapter endeavors to provide the participants with resources for scientific and technical information and educational opportunities. It facilitates meetings and exchange of information with industry representatives from large and small companies, biotech manufacturers, medical device manufacturers, equipment vendors, Ministry of Health officials, academics and consultants. The meetings allow to exchange evolving information on the latest guidances and regulations concerning pharmaceutical operations and regulatory requirements. These meetings are either Seminars (both online and in-person), or Conferences and Meetings. In addition, the Chapter provides access to PDA Israel seminars and webinars materials through the PDA Israel website.
Membership in global PDA
PDA Membership Benefits
PDA strives to offer superior value and services to its members. These benefits provide the members with resources for scientific and technical information, educational opportunities, and enhancement of practical skills. As a PDA member, you will have access to many beneficial resources, including:
- A subscription to the PDA Journal of Pharmaceutical Science and Technology
The Journal is considered one of the most relevant and highly cited vehicles for peer-reviewed scientific and technical papers in the pharmaceutical and biotech industries.
- A subscription to International Pharmaceutical Quality (IPQ)
provides an in-depth analysis of problems in the forefront of the regulatory debate, with a focus on the efforts to improve and harmonize the regulation of pharmaceutical quality, as well as internal corporate quality systems.
- PDA Technical Reports as they are published
PDA Technical Reports cover a wide variety of subjects relating to pharmaceutical production, validation and quality assurance.
- A subscription to the PDA Letter
The PDA Letter is PDA's membership publication covering the science, technology, quality, regulatory affairs, association news and updates relevant to the PDA community.
- Substantial registration discounts on all PDA conferences, Training and Research Institute (TRI) courses, web seminars and publications.
- Access to the member's only section of global PDA website.
- Online Membership Directory, Draft Technical Documents, PDA Letter and Technical Presentation Archive, Interest Group Minutes and Presentation and much more.
